Published in Trends Parasitol on March 20, 2006
Clinical significance of enteric protozoa in the immunosuppressed human population. Clin Microbiol Rev (2009) 2.34
Identification of zoonotic genotypes of Giardia duodenalis. PLoS Negl Trop Dis (2009) 2.06
Persistent G. lamblia impairs growth in a murine malnutrition model. J Clin Invest (2013) 1.81
Molecular surveillance of Cryptosporidium spp., Giardia duodenalis, and Enterocytozoon bieneusi by genotyping and subtyping parasites in wastewater. PLoS Negl Trop Dis (2012) 1.60
Enteric protozoa in the developed world: a public health perspective. Clin Microbiol Rev (2012) 1.52
Prevalence and Risk Factors for Intestinal Protozoan Infections with Cryptosporidium, Giardia, Blastocystis and Dientamoeba among Schoolchildren in Tripoli, Lebanon. PLoS Negl Trop Dis (2016) 1.45
Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites. Clin Microbiol Rev (2007) 1.45
Kinesin-13 regulates flagellar, interphase, and mitotic microtubule dynamics in Giardia intestinalis. Eukaryot Cell (2007) 1.45
Factors associated with parasitic infection amongst street children in orphanages across Lima, Peru. Pathog Glob Health (2013) 1.43
Dogs as sources and sentinels of parasites in humans and wildlife, northern Canada. Emerg Infect Dis (2008) 1.38
Multilocus genotyping of human Giardia isolates suggests limited zoonotic transmission and association between assemblage B and flatulence in children. PLoS Negl Trop Dis (2011) 1.29
Mini-FLOTAC, an innovative direct diagnostic technique for intestinal parasitic infections: experience from the field. PLoS Negl Trop Dis (2013) 1.29
A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia. Antimicrob Agents Chemother (2013) 1.22
Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol (2013) 1.17
Cryptosporidium infection causes undernutrition and, conversely, weanling undernutrition intensifies infection. J Parasitol (2008) 1.16
Global distribution, public health and clinical impact of the protozoan pathogen cryptosporidium. Interdiscip Perspect Infect Dis (2010) 1.15
The biological activity of auranofin: implications for novel treatment of diseases. Inflammopharmacology (2012) 1.15
A new family of giardial cysteine-rich non-VSP protein genes and a novel cyst protein. PLoS One (2006) 1.13
Large outbreak of Cryptosporidium hominis infection transmitted through the public water supply, Sweden. Emerg Infect Dis (2014) 1.09
Effects of hygiene and defecation behavior on helminths and intestinal protozoa infections in Taabo, Côte d'Ivoire. PLoS One (2013) 1.09
Disruption of antigenic variation is crucial for effective parasite vaccine. Nat Med (2010) 1.09
Life with eight flagella: flagellar assembly and division in Giardia. Curr Opin Microbiol (2010) 1.07
Rapid tagging and integration of genes in Giardia intestinalis. Eukaryot Cell (2010) 1.00
Using morpholinos for gene knockdown in Giardia intestinalis. Eukaryot Cell (2009) 1.00
Rapid identification of Giardia duodenalis by loop-mediated isothermal amplification (LAMP) from faecal and environmental samples and comparative findings by PCR and real-time PCR methods. Parasitol Res (2009) 1.00
Prevalence and risk factors for Giardia duodenalis infection among children: a case study in Portugal. Parasit Vectors (2012) 0.99
Giardia flagellar motility is not directly required to maintain attachment to surfaces. PLoS Pathog (2011) 0.98
Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. Nat Rev Microbiol (2013) 0.98
Intestinal parasitic infections among children in central Albania. Ann Trop Med Parasitol (2011) 0.97
High-resolution crystal structure and in vivo function of a kinesin-2 homologue in Giardia intestinalis. Mol Biol Cell (2008) 0.97
"Barriers" to child development and human potential: the case for including the "neglected enteric protozoa" (NEP) and other enteropathy-associated pathogens in the NTDs. PLoS Negl Trop Dis (2013) 0.96
Prevalence and associated risk factors of Giardia infection among indigenous communities in rural Malaysia. Sci Rep (2014) 0.94
Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens. Clin Vaccine Immunol (2010) 0.93
A smartphone-based chip-scale microscope using ambient illumination. Lab Chip (2014) 0.91
Novel structural components of the ventral disc and lateral crest in Giardia intestinalis. PLoS Negl Trop Dis (2011) 0.91
Burden of Giardia duodenalis infection and its adverse effects on growth of schoolchildren in rural Malaysia. PLoS Negl Trop Dis (2013) 0.91
Detection of Giardia duodenalis assemblages A and B in human feces by simple, assemblage-specific PCR assays. PLoS Negl Trop Dis (2012) 0.90
SGLT-1-mediated glucose uptake protects human intestinal epithelial cells against Giardia duodenalis-induced apoptosis. Int J Parasitol (2008) 0.90
Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. BMC Infect Dis (2009) 0.90
Giardia and Cryptosporidium and public health: the epidemiological scenario from the Italian perspective. Parasitol Res (2007) 0.90
Advances in understanding Giardia: determinants and mechanisms of chronic sequelae. F1000Prime Rep (2015) 0.90
The cenH3 histone variant defines centromeres in Giardia intestinalis. Chromosoma (2006) 0.89
Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia. Antimicrob Agents Chemother (2011) 0.89
Plasmid vectors for proteomic analyses in Giardia: purification of virulence factors and analysis of the proteasome. Eukaryot Cell (2012) 0.89
Determination of Giardia duodenalis assemblages and multi-locus genotypes in patients with sporadic giardiasis from England. Parasit Vectors (2015) 0.89
Identification of genotypes of Giardia duodenalis human isolates in Isfahan, Iran, using polymerase chain reaction - Restriction Fragment Length polymorphism. Adv Biomed Res (2012) 0.89
Evaluation of a screening test for detection of giardia and cryptosporidium parasites. J Clin Microbiol (2008) 0.88
Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseases. Gut Microbes (2012) 0.88
Generating human intestinal tissues from pluripotent stem cells to study development and disease. EMBO J (2015) 0.88
Glucosylceramide synthesis inhibition affects cell cycle progression, membrane trafficking, and stage differentiation in Giardia lamblia. J Lipid Res (2010) 0.87
The role of arginine and arginine-metabolizing enzymes during Giardia - host cell interactions in vitro. BMC Microbiol (2013) 0.87
The Cryptosporidium parvum kinome. BMC Genomics (2011) 0.86
The Giardia median body protein is a ventral disc protein that is critical for maintaining a domed disc conformation during attachment. Eukaryot Cell (2012) 0.86
Molecular characterization of the cis-prenyltransferase of Giardia lamblia. Glycobiology (2010) 0.86
Intestinal parasitoses in a tertiary-care hospital located in a non-endemic setting during 2006-2010. BMC Infect Dis (2014) 0.85
Giardia duodenalis cathepsin B proteases degrade intestinal epithelial interleukin-8 and attenuate interleukin-8-induced neutrophil chemotaxis. Infect Immun (2014) 0.84
A detailed, hierarchical study of Giardia lamblia's ventral disc reveals novel microtubule-associated protein complexes. PLoS One (2012) 0.84
Epidemiology of Giardia duodenalis infection in ruminant livestock and children in the Ismailia province of Egypt: insights by genetic characterization. Parasit Vectors (2014) 0.83
Evaluation of a PCR protocol for sensitive detection of Giardia intestinalis in human faeces. Parasitol Res (2011) 0.83
Tonic shock induces detachment of Giardia lamblia. PLoS Negl Trop Dis (2008) 0.83
Prevalence and risk factors for giardiasis and soil-transmitted helminthiasis in three municipalities of Southeastern Minas Gerais State, Brazil: risk factors for giardiasis and soil-transmitted helminthiasis. Parasitol Res (2011) 0.83
Reducing occurrence of Giardia duodenalis in children living in semiarid regions: impact of a large scale rainwater harvesting initiative. PLoS Negl Trop Dis (2014) 0.83
Macrophages expressing arginase 1 and nitric oxide synthase 2 accumulate in the small intestine during Giardia lamblia infection. Microbes Infect (2015) 0.83
Cryptosporidium spp., Giardia duodenalis, Enterocytozoon bieneusi and other intestinal parasites in young children in Lobata province, Democratic Republic of São Tomé and Principe. PLoS One (2014) 0.82
Hsp90 inhibitors as new leads to target parasitic diarrheal diseases. Antimicrob Agents Chemother (2014) 0.82
New drug target in protozoan parasites: the role of thioredoxin reductase. Front Microbiol (2015) 0.82
Discovery of novel antigiardiasis drug candidates. Antimicrob Agents Chemother (2014) 0.81
Genetic diversity of Giardia duodenalis: multilocus genotyping reveals zoonotic potential between clinical and environmental sources in a metropolitan region of Brazil. PLoS One (2014) 0.81
Occurrence and genetic characterization of Giardia duodenalis from captive nonhuman primates by multi-locus sequence analysis. Parasitol Res (2011) 0.81
Genotyping and phylogenetic analysis of Giardia duodenalis isolates from Turkish children. Med Sci Monit (2015) 0.81
Case-Control Study of Risk Factors for Sporadic Giardiasis and Parasite Assemblages in North West England. J Clin Microbiol (2015) 0.81
Disruptions of Host Immunity and Inflammation by Giardia Duodenalis: Potential Consequences for Co-Infections in the Gastro-Intestinal Tract. Pathogens (2015) 0.80
Crystal structure of a macrophage migration inhibitory factor from Giardia lamblia. J Struct Funct Genomics (2013) 0.80
Burden of diarrhea, hospitalization and mortality due to cryptosporidial infections in Indian children. PLoS Negl Trop Dis (2014) 0.80
Hospitalization of Cuban children for giardiasis: a retrospective study in a paediatric hospital in Havana. Ann Trop Med Parasitol (2011) 0.80
Multilocus genotyping of Giardia duodenalis isolates from children in Oromia Special Zone, central Ethiopia. BMC Microbiol (2016) 0.79
Giardia lamblia Nek1 and Nek2 kinases affect mitosis and excystation. Int J Parasitol (2012) 0.79
A Bibliometric and Trend Analysis on the Water-Related Risk Assessment Studies for Cryptosporidium Pathogen. Iran J Parasitol (2015) 0.79
The microRNAs in an ancient protist repress the variant-specific surface protein expression by targeting the entire coding sequence. PLoS Pathog (2014) 0.79
Intraepithelial giardia intestinalis: a case report and literature review. Medicine (Baltimore) (2014) 0.79
Molecular Characterization and Risk Factors of Giardia duodenalis among School Children from La Habana, Cuba. J Parasitol Res (2015) 0.79
Incidence of Giardia lamblia Subspecies by PCR-RFLP in Stool Specimens of Hospitalized Children at Urmia Mutahhari Hospital, West Azerbaijan Province, Iran. Iran J Parasitol (2015) 0.78
High occurrence of Blastocystis sp. subtypes 1-3 and Giardia intestinalis assemblage B among patients in Zanzibar, Tanzania. Parasit Vectors (2016) 0.78
High sensitivity of Giardia duodenalis to tetrahydrolipstatin (orlistat) in vitro. PLoS One (2013) 0.78
A Sensitive and Specific PCR Based Method for Identification of Cryptosporidium Sp. Using New Primers from 18S Ribosomal RNA. Iran J Parasitol (2011) 0.78
Prevalence and genotyping of Cryptosporidium species from farm animals in Mongolia. Parasitol Res (2008) 0.78
Immunolocalization of α18- and α12-giardin in Giardia lamblia trophozoites. Parasitol Res (2016) 0.78
Development of a Diagnostic Kit to Detect Cryptosporidium parvum and Giardia lamblia. Osong Public Health Res Perspect (2013) 0.78
Efficacy of eleven antimicrobials against a gregarine parasite (Apicomplexa: Protozoa). Ann Clin Microbiol Antimicrob (2007) 0.78
The invasive potential of Giardia intestinalis in an in vivo model. Sci Rep (2015) 0.78
Human zoonotic enteropathogens in a constructed free-surface flow wetland. Parasitol Res (2009) 0.78
An evaluation of primers amplifying DNA targets for the detection of Cryptosporidium spp. using C. parvum HNJ-1 Japanese isolate in water samples. Parasitol Res (2007) 0.78
Antibody and cytokine responses to Giardia excretory/secretory proteins in Giardia intestinalis-infected BALB/c mice. Parasitol Res (2014) 0.78
Anti-giardial therapeutic potential of dichloromethane extracts of Zingiber officinale and Curcuma longa in vitro and in vivo. Parasitol Res (2016) 0.77
Spatial Modelling Tools to Integrate Public Health and Environmental Science, Illustrated with Infectious Cryptosporidiosis. Int J Environ Res Public Health (2016) 0.77
Parental perceptions of giardiasis: a study in an outpatient paediatric hospital setting in havana, cuba. ISRN Prev Med (2012) 0.77
Giardia duodenalis Surface Cysteine Proteases Induce Cleavage of the Intestinal Epithelial Cytoskeletal Protein Villin via Myosin Light Chain Kinase. PLoS One (2015) 0.77
Increased expression of CD25, CD83, and CD86, and secretion of IL-12, IL-23, and IL-10 by human dendritic cells incubated in the presence of Toll-like receptor 2 ligands and Giardia duodenalis. Parasit Vectors (2013) 0.77
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med (1978) 15.13
General practitioner's perceptions of the route to evidence based medicine: a questionnaire survey. BMJ (1998) 13.39
Antibodies to ribosomes in chronic active hepatitis. Gastroenterology (1979) 12.78
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
Randomized versus historical controls for clinical trials. Am J Med (1982) 7.53
Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol (2007) 7.30
Performance indicators for primary care groups: an evidence based approach. BMJ (1998) 6.97
A method for assessing the quality of a randomized control trial. Control Clin Trials (1981) 6.63
Structural basis of cell-cell adhesion by cadherins. Nature (1995) 6.56
Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell (1991) 6.28
Spectrographic data concerning vitamin A and liver oils. Biochem J (1931) 6.14
Microbial surfaces in relation to pathogenicity. Bacteriol Rev (1977) 5.79
Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med (2000) 5.68
Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell (1992) 5.29
X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. Science (1999) 4.78
Bias in treatment assignment in controlled clinical trials. N Engl J Med (1983) 4.78
Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ (2010) 4.53
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Publication bias and clinical trials. Control Clin Trials (1987) 4.34
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Altered electrical properties in Drosophila neurons developing without synaptic transmission. J Neurosci (2001) 3.80
Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest (1996) 3.74
MR imaging and T2 mapping of femoral cartilage: in vivo determination of the magic angle effect. AJR Am J Roentgenol (2001) 3.69
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain (2001) 3.51
Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA (1995) 3.48
Future provision of out of hours primary medical care: a survey with two general practitioner research networks. BMJ (1996) 3.34
Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med (1977) 3.33
Paediatric intensive care transfers. Anaesthesia (2000) 3.32
The crystal structure of dimeric kinesin and implications for microtubule-dependent motility. Cell (1997) 3.17
Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. Oncogene (2006) 3.09
Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med (1983) 3.04
Appropriateness of use of emergency ambulances. J Accid Emerg Med (1998) 3.02
Rate of regeneration of peripheral nerves in man. J Physiol (1943) 3.02
Transgene-mediated auxin overproduction in Arabidopsis: hypocotyl elongation phenotype and interactions with the hy6-1 hypocotyl elongation and axr1 auxin-resistant mutants. Plant Mol Biol (1995) 3.01
Infection and diabetes: the case for glucose control. Am J Med (1982) 2.90
Is perinatal mortality still a good indicator of perinatal care? Paediatr Perinat Epidemiol (1988) 2.87
Pathogenicity of influenza virus. Microbiol Rev (1980) 2.80
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 2.66
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65
Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature (1992) 2.61
In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med (1990) 2.61
An activating mutation of AKT2 and human hypoglycemia. Science (2011) 2.60
Structure of a cephalosporin synthase. Nature (1998) 2.59
A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med (1981) 2.59
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection. Lancet (1991) 2.41
Derivatives of 6-aminopenicillanic acid. XI. Alpha-amino-p-hydroxybenzylpenicillin. J Chem Soc Perkin 1 (1971) 2.39
La Crosse encephalitis in children. N Engl J Med (2001) 2.38
Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Q J Med (1967) 2.38
Genetic engineering of harvest index in tobacco through overexpression of a phytochrome gene. Nat Biotechnol (1996) 2.36
Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess (2009) 2.36
Overnight calls in primary care: randomised controlled trial of management using nurse telephone consultation. BMJ (1999) 2.32
Phytochrome and photomorphogenesis in plants. Nature (1970) 2.26
Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int (2006) 2.23
Doppler echocardiographic measurement of low velocity motion of the left ventricular posterior wall. Am J Cardiol (1989) 2.23
Automation of sample mounting for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2006) 2.22
Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet (1984) 2.19
Earthquake injuries related to housing in a guatemalan village. Science (1977) 2.18
The pathophysiology of HOX genes and their role in cancer. J Pathol (2005) 2.18
Clinical governance in primary care groups: the feasibility of deriving evidence-based performance indicators. Qual Health Care (2000) 2.16
Increase of oleic acid in erythrocytes associated with malignancies. Br Med J (Clin Res Ed) (1985) 2.15
Preventive care for patients following myocardial infarction. The Wessex Research Network (WReN). Fam Pract (1997) 2.15
Biochemical challenge of microbial pathogenicity. Bacteriol Rev (1968) 2.14
Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene (2007) 2.14
The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med (1978) 2.05
Women's views about management and cause of urinary tract infection: qualitative interview study. BMJ (2010) 2.03
Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial. BMJ (2000) 1.99
Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet (1988) 1.98
Comparison of ultrasound measurements at the heel between adults with mental retardation and control subjects. Bone (1998) 1.97
During infection of epithelial cells Salmonella enterica serovar Typhimurium undergoes a time-dependent transcriptional adaptation that results in simultaneous expression of three type 3 secretion systems. Cell Microbiol (2007) 1.94
Groin hernia repair in Scotland. Br J Surg (2000) 1.93
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain (2000) 1.89
Food intolerance and the irritable bowel syndrome. Gut (1989) 1.88
Selection from gonococci grown in vitro of a colony type with some virulence properties of organisms adapted in vivo. J Gen Microbiol (1977) 1.85
Anthrax toxic complex. Fed Proc (1967) 1.84
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. Microb Pathog (1988) 1.81
Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid. Microb Pathog (1989) 1.80
Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med (1992) 1.80
Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut (1979) 1.78
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol (1997) 1.72
ICAP-1, a novel beta1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of beta1 integrin. J Cell Biol (1997) 1.72
Characterization of the ABA-deficient tomato mutant notabilis and its relationship with maize Vp14. Plant J (1999) 1.72
Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum. J Gen Microbiol (1988) 1.72
1% or less: a community-based nutrition campaign. Public Health Rep (1998) 1.69
Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet (1991) 1.67
Hydrogenated oils and fats: the presence of chemically-modified fatty acids in human adipose tissue. Am J Clin Nutr (1981) 1.65
Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine (1999) 1.63
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Sinonasal and sino-orbital aspergillosis in 23 cats: aetiology, clinicopathological features and treatment outcomes. Vet J (2011) 1.63
Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can J Vet Res (1998) 1.63
Alpha gliadin antibody levels: a serological test for coeliac disease. Br Med J (Clin Res Ed) (1983) 1.62
KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation. Am J Transplant (2011) 1.62